The Canadian environment for innovation and business development in the biotechnology industry: A firm-level analysis

European Planning Studies

Volumn 12, Issue 7, 2004, Pages 961-983

  Bagchi Sen, Sharmistha ^a   Scully, Jennifer L ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; BUSINESS DEVELOPMENT; FOREIGN DIRECT INVESTMENT; INNOVATION; RESEARCH AND DEVELOPMENT;

CANADA; NORTH AMERICA; WESTERN HEMISPHERE; WORLD;

EID: 10244255054     PISSN: 09654313     EISSN: None     Source Type: Journal    
DOI: 10.1080/0965431042000267867     Document Type: Article

References (49)

1. Amit, R., Brander, J. and Zott, C. (1998) Why do Venture Capital Firms Exist? Theory and Canadian Evidence, Journal of Business Venturing 13(6) pp. 441-466.
2. Arundel, A. and Rose, A. (1999) The Diffusion of Environmental Biotechnology in Canada: Adoption Strategies and Cost Offsets, Technovation, 19(9) pp. 551-560.
3. Audretsch, D.B., and Stephan, P.E. (1996) Company-Scientist Locational Links: The Case of Biotechnology, The American Economic Review, 86(3) pp. 641-652.
4. Audretsch, D. and Stephan, P. (2000) Knowledge spillovers in biotechnology: sources and incentives, Journal of Evolutionary Economics , 9, pp. 97-107.
5. Bagchi-Sen, S., Hall, L. and Petryshan, L. (2001) A Study of University-industry Linkages in the Biotechnology Industry: Perspectives from Canada, International Journal of Biotechnology, 3(3/4) pp. 390-410.
6. Belem, M. A. F. (1999) Application of Biotechnology in the Product Development of Nutraceuticals in Canada, Trends in Food Science and Technology, 10(3) pp. 101-106.
7. BRAVO - Industry Canada (2003) BRAVO Introduction, http://www.bravo.ic.gc.ca/biotech/body.htm
8. Canadian Biotechnology Advisory Committee (2003) Canadian Biotechnology Advisory Committee - About Us, .
9. Canadian Biotechnology Strategy (1998) CBS Online - Related Resources Documents. 1983 National Biotechnology Strategy, http://biotech.gc.ca/archives/engdoc/bh00194e.html
10. Cooke, P. (2002) Rational drug design and the rise of bioscience megacentres. Presented at the Fourth Triple Helix Conference on Breaking Boundaries-Building Bridges, Copenhagen, Denmark-Lund, Sweden, November 6-9.
11. Cooke, P. (1998) Introduction: origins of the concept. In H-J. BRACZYK, P. COOKE, and M. HEINDENREICH, Rgional Innovation Systems. (Eds) pp. 2-27. London, UK: UCL Press.
12. Coombs, J.E. and Deeds, D.L. (2000) International alliances as sources of capital: evidence from the biotechnology industry, The Journal of High Technology Management Research, 11(2) pp. 235-253.
13. Cumby, J. and Conrod, J. (2001) Assessing Value Creation in the Canadian Biotechnology Industry. Proceedings of the 31st Annual Atlantic Schools of Business Conference, Halifax, Nova Scotia.
14. Gertler, M.S. (2001a) Central Canada and the Global Economy: Politics and Possibilities, Canadian Geographer, 45(1) pp. 31-35.
15. Gertler, M.S. (2001b) Urban Economy and Society in Canada: Flows of People, Capital and Ideas, The Canadian Journal of Policy Research 2(3) pp. 119-130.
16. Gertler, M.S., WOLFE, D.A. and GARKUT, D. (2000) No Place Like Home? The Embeddedness of Innovation in a Regional Economy, Review of International Political Economy, 7(4) pp. 688-718.
17. Government of Canada (2002) Biotechnology Advancing Society, Canada Leading the Way, Canadian Biotechnology Advisory Committee, http://cbac-cccb.ca
18. Hall, S. (1987) Invisible Frontiers: The Race to Synthesize a Human Gene. London: Sidgwick and Jackson.
19. Hall, L. and Bagghi-Sen, S. (2002) A Study of R&D, innovation and business performance in the Canadian biotechnology industry, Technovation, 22, pp. 231-244.
20. Hall, L. and Bagchi-Sen, S. (2001) An Analysis of R&D, innovation and business performance in the US biotechnology industry, International Journal of Biotechnology, 3(3/4) pp. 267-286.
21. Li, S. and Tomalin, A. (2002) Patentees Research and Development Expenditure in Canada, Journal of Pharmaceutical Science, 5(1) pp. 5-11.
22. Liebeskind, J. P., Oliver, A. L., Zucker, L. G., and Brewer, M. B. (1995) Social Network, Learning and Flexibility: Sourcing Scientific Knowledge in New Biotechnology Firms. NBER Working Paper Series, No. 5320. National Bureau of Economic Research, Cambridge, MA.
23. Maleckl, E.J. (1997) Technology and Economic Development. Essex, UK: Addison Wesley Longman Limited.
24. McNiven, C. (2001) Biotechnology Use and Development - 1999, Statistics Canada, Cat. No. 88F0006XIE01007.
25. Nightingale, P. (2000) Economies of Scale in Experimentation: Knowledge and Technology in Pharmaceutical R&D, Industrial and Corporate Change 9, pp. 315-359.
26. Niosi, J. and Bas, T. (2001) The Competencies of Regions - Canada's Clusters in Biotechnology, Small Business Economics, 17, pp. 31-42.
27. National Research Council Canada (2003) Biotechnology - National Research Council, http://www.nrc-cnrc.gc.ca/randd/areas/biotechnology_e.html
28. Oinas, P. and Malecki, E.J. (2002) The evolution of technologies in time and space: from national and regional to spatial innovation systems, International Regional Science Review, 25, pp. 102-131.
29. Patented Medicine Prices Review Board (2002a) New Patented Medicines Reported to PMPRB - 2002.
30. Patented Medicine Prices Review Board (2002b) New Patented Medicines Reported to PMPRB - 2001.
31. Patented Medicine Prices Review Board (2002c) New Patented Medicines Reported to PMPRB - 2000.
32. Patented Medicine Prices Review Board (2002d) New Patented Medicines Reported to PMPRB - 1999.
33. Patented Medicine Prices Review Board (2002e) New Patented Medicines Reported to PMPRB - 1998.
34. Pisano, G. (1991) The governance of innovation: vertical integration and collaborative arrangements in the biotechnology industry, Research Policy, 20, pp. 237-249.
35. Pisano, G., Shan, W., and Teece, D. J. (1988) Joint ventures and collaboration in the biotechnology industry, in D. MOWERY (Ed.), International Collaborative Ventures in U.S. Manufacturing Cambridge, MA: Ballinger Publishing Co.
36. Powell, W.W., Koput, K.W., Bowie, J.I., Smith-Doerr, L. (2002) The spatial clustering of science and capital: accounting for biotech firm-venture capital relationships, Regional Studies, 36(3) pp. 291-305.
37. Prevezer, M. (1998) Clustering in Biotechnology in the USA. In G.M. PETER SWANN, M. PREVEZER and D. STOUT, The Dynamics of Industrial Clustering. pp. 124-193. Oxford: Oxford University Press.
38. Rose, A. (1998) Biotechnology Use by Canadian Industry - 1996. Science and Technology Redesign Project, Statistics Canada, ST-98-05.
39. Strachan, G. (1995) The Impact of Regulations on the Growth and Evolution of Canadian Commercial Biotechnology, Current Opinion in Biotechnology, 6(3) pp. 261-263.
40. Strategis Canada (2002) The Biotechnology Gateway: Overview of Biotechnology. http://strategis.ic.gc.ca/SSG/bo01544e.html.
41. Statistics Canada (2002a) We Have Learned a Great Deal!, Innovation Analysis Bulletin, 4(1) pp. 3-6.
42. Statistics Canada (2002b) IP Protection Practices by Manufacturing Firms, Innovation Analysis Bulletin, 4(1) pp. 7-10.
43. Statistics Canada (2002c) A Profile of Spin-off Firms in the Biotechnology Sector, Innovation Analysis Bulletin, 4(1) pp. 12.
44. Swann, G.M. Peter, Prevezer, M. and Stout, D. (1998) The Dynamics of Industrial Clustering. Oxford, UK: Oxford University Press.
45. White, K. (2000) Economic Profile of the Biotechnology Sector, The Canadian Biotechnology Advisory Committee Project Steering Committee Intellectual Property and the Patenting of Higher Life Forms.
46. Woiceshyn, J. and Hartel, D. (1996) Strategies and Performance of Canadian Biotechnology Firms: An Empirical Investigation, Technovation, 16(5) pp. 231-243.
47. Wolfe, D.A., and Gertler, M.S. (2001) Globalization and Economic Restructuring in Ontario: From Industrial Heartland to Learning Region, European Planning Studies, 9(5) pp. 575-592.
48. Zucker, L.G., Darby, M.R., and Armstrong, J.S. (2002) Commercializing knowledge: university science, knowledge capture, and firm performance in biotechnology, Management Science, 48(1) pp. 138-153.
49. Zucker, L.G., Darby, M.R., and Brewer, M.B. (1998) Intellectual Human Capital and the Birth of U.S. Biotechnology Enterprises, American Economic Review, 88(1) pp. 290-306.